Medhat Askar
Overview
Explore the profile of Medhat Askar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1016
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumanovics A, Askar M, Sadighi Akha A
J Immunol Methods
. 2025 Feb;
537:113822.
PMID: 39892827
No abstract available.
2.
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro R, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1139-1154.
PMID: 39260570
Donor-specific anti-HLA antibodies (DSA) are an important cause of engraftment failure and may negatively impact survival outcomes of patients receiving allogeneic hematopoietic stem cell transplantation (HSCT) using an HLA-mismatched allograft....
3.
Blouin A, Nelson W, Geraghty D, Askar M, Ye F
J Mol Diagn
. 2024 Aug;
26(11):995-1006.
PMID: 39181323
Chimerism analysis by next-generation sequencing (NGS) is an emerging method for engraftment monitoring after allogeneic hematopoietic cell transplantation. A high-sensitivity method is required for the detection of microchimerism (<1% chimerism),...
4.
Johannesson L, Wood-Trageser M, Lesniak D, Punar M, Klingman L, Naziruddin B, et al.
Clin Transplant
. 2024 Aug;
38(8):e15434.
PMID: 39166465
Introduction: Uterus transplantation (UTx) is a novel treatment for absolute uterine infertility. Acute T cell-mediated rejection (TCMR) can be monitored only through serial cervical biopsies. Methods: This study, the first...
5.
Hedskog C, Spinner C, Protzer U, Hoffmann D, Ko C, Gottlieb R, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675889
Remdesivir (RDV) is a broad-spectrum nucleotide analog prodrug approved for the treatment of COVID-19 in hospitalized and non-hospitalized patients with clinical benefit demonstrated in multiple Phase 3 trials. Here we...
6.
Kozlitina J, Cohen N, Sturtevant D, Cohen J, Murphey-Half C, Saltarrelli J, et al.
EClinicalMedicine
. 2024 Jan;
67:102350.
PMID: 38169797
Background: Several genetic variants are associated with chronic liver disease. The role of these variants in outcomes after liver transplantation (LT) is uncertain. The aim of this study was to...
7.
Shi Q, Jiang X, Li M, Fang J, Fu Z, Zhu S, et al.
Transpl Immunol
. 2023 Nov;
82:101963.
PMID: 38013122
Background: Microvascular injury resulting from activation and exocytosis are early signs of tissue damage caused by allografting. However, humoral anti-graft reactions are not easily detectable in transplant biopsies. The aim...
8.
Huang H, Schechtman K, Askar M, Bernadt C, Mitter B, Dore P, et al.
Transplantation
. 2023 Oct;
108(3):777-786.
PMID: 37899481
Background: Chronic lung allograft dysfunction (CLAD) is the leading cause of death beyond the first year after lung transplantation. The development of donor-specific antibodies (DSA) is a recognized risk factor...
9.
OLeary J, Farris A, Gebel H, Asrani S, Askar M, Garcia V, et al.
Transplant Direct
. 2023 Jul;
9(8):e1500.
PMID: 37456590
Methods: We reevaluated allograft biopsies from simultaneous liver-kidney transplant recipients who had both allografts biopsied within 60 d of one another and within 30 d of DSA being positive in...
10.
Truong L, Matern B, El-Lagta N, Mobegi F, Askar M, Ogret Y, et al.
HLA
. 2023 Jul;
102(6):690-706.
PMID: 37452528
The primary goal of the HLA-DPA1 ~ promoter ~ HLA-DPB1 haplotype component of the 18th IHIWS was to characterise the extended haplotypes within the HLA-DP region and survey the extent...